Medison Debuts at 2025 Shanghai CMEF, Empowering a New Future of Healthcare with Precision SolutionsShanghai, April 8, 2025 / Healthcare News / – The 93rd China International Medical Equipment Fair (CMEF) grandly opened at the National Exhibition and Convention Center (Shanghai). Weihai Medison Medical Equipment Co., Ltd. made a prominent appearance with innovative products and one-stop solutions covering vascular intervention, urology, gynecology, medical cosmetology and other sectors. With over 20 years of technological accumulation and independent R&D capabilities, the company showcased the innovative breakthroughs and quality benchmarks of domestic medical devices, injecting new momentum into the global healthcare industry.
Under the theme of “Innovative Technology, Leading the Future”, CMEF 2025 brings together nearly 5,000 medical enterprises worldwide, featuring cutting-edge technologies and products across the entire industrial chain. As the largest and most influential medical industry event in the Asia-Pacific region, it is known as the global “weather vane” of healthcare. Leveraging its professional R&D and manufacturing strengths, Medison focused on clinical pain points and market demands, presenting a full range of core products including small and medium-sized equipment, medical consumables, biological preparations and raw materials, demonstrating its innovative achievements in precision medicine, efficient diagnosis and treatment, and safety protection, making it a highly watched domestic medical brand at the exhibition.
Breakthroughs in Four Core Areas, Unlocking New Possibilities for Precision Medicine
Rooted in clinical needs and technological innovation, Medison has deeply cultivated four core fields: vascular intervention, urology, gynecology and medical cosmetology. It continuously tackles key industry technical challenges and provides efficient, safe and adaptable solutions for medical institutions.
In vascular intervention, Medison optimizes the maneuverability and safety of interventional consumables based on independent R&D technologies. Its products align with clinical surgical procedures, helping improve the accuracy and success rate of interventional surgeries and supporting reliable diagnosis and treatment of cardiovascular diseases. In urology, the company focuses on minimally invasive diagnosis and treatment, launching a variety of miniaturized and intelligent equipment and consumables. Featuring minimal trauma, fast recovery and easy operation, they reduce patient suffering and fit diverse medical scenarios in primary and high-end medical institutions.
In gynecological diagnosis and treatment, Medison devotes itself to women’s health, developing a range of special equipment and consumables that balance safety and comfort, supporting early screening, diagnosis and treatment of gynecological diseases and safeguarding women’s health throughout their life cycle. In medical cosmetology, the company’s syringe-assisted driving devices and other products precisely meet clinical needs such as facial injection, with stable operation and accurate dosage control. They provide standardized and safe operation solutions for medical aesthetic institutions and promote the standardized development of the industry.
At this exhibition, many new Medison products attracted numerous merchants for negotiation due to their innovative design and excellent quality. Among them, the new minimally invasive interventional consumables enable more convenient surgical operations with lightweight materials and precise structure; gynecological special diagnostic equipment integrates intelligent sensing technology to improve detection efficiency and accuracy; medical aesthetic auxiliary devices meet EU CE certification standards, combining safety and practicality, and have been highly recognized by customers at home and abroad.
Adhering to Quality, Building a Solid Foundation for Domestic Medical Brands
Founded in 2003, Weihai Medison Medical Equipment Co., Ltd. has focused on the R&D, production and sales of medical devices for more than 20 years. It now owns more than 50 independent patents and has formed a professional system covering the whole chain of R&D, production, quality inspection and sales. The company has successively passed EU CE certification and ISO 13485 medical device quality management system certification, strictly controlling product quality in line with international standards to ensure the safety and reliability of every product.
With continuous technological innovation and excellent product quality, Medison was awarded “The First Batch of Technological Innovation Projects in Shandong Province” in March 2018, recognized as a High-Tech Enterprise jointly by the Department of Science and Technology, Department of Finance and Taxation Bureau of Shandong Province in November 2018, and successfully listed on the New OTC Market in February 2018, becoming an innovative benchmark enterprise in the medical device field of Shandong. The company gathers a professional and high-level expert team, deeply engages in technological R&D and process optimization, continuously breaks through industry technical bottlenecks, promotes the iterative upgrading of small and medium-sized medical equipment, consumables, biological preparations and other products, responds to clinical needs with innovative technologies, and serves the global health cause with high-quality products.
In the future, Medison will continue to uphold the philosophy of “innovation-driven and quality first”, deeply cultivate core fields of medical devices, continuously increase R&D investment, strengthen technological innovation and achievement transformation, and constantly launch medical products that better meet clinical needs and are more competitive in the market. It will help domestic medical devices move toward high-end, intelligent and internationalization, and contribute to the development of the global healthcare industry.
